Ellevest, Inc. Uro Gen Pharma Ltd. Transaction History

Ellevest, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 03, 2023	SELL	$7.55 - $11.96 $181 - $287	-24 Reduced 35.82%	43 $0
Q3 2022 Nov 02, 2022	SELL	$7.21 - $9.41 $317 - $414	-44 Reduced 39.64%	67 $1,000
Q2 2022 Jul 18, 2022	SELL	$5.12 - $8.74 $2,022 - $3,452	-395 Reduced 78.06%	111 $1,000
Q1 2022 Apr 19, 2022	BUY	$5.92 - $9.73 $2,107 - $3,463	356 Added 237.33%	506 $4,000
Q4 2021 Jan 24, 2022	SELL	$9.03 - $19.13 $108 - $229	-12 Reduced 7.41%	150 $1,000
Q3 2021 Oct 19, 2021	BUY	$14.31 - $18.39 $1,230 - $1,581	86 Added 113.16%	162 $3,000
Q2 2021 Jul 13, 2021	BUY	$15.2 - $20.94 $638 - $879	42 Added 123.53%	76 $1,000
Q1 2021 May 03, 2021	BUY	$17.99 - $26.96 $611 - $916	34 New	34 $1,000

130

35.9M

22K

93.8K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $242M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.